tiprankstipranks
Genmab (Otc) (GMAB)
NASDAQ:GMAB
Want to see GMAB full AI Analyst Report?

Compare Genmab (GMAB) vs. Competitors

776 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Genmab
$28.55
$16.00B
77.40
33.84%
7 Buy
2 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$54.64
$9.70B
25.76
-16.24%
16 Buy
6 Hold
0 Sell
Moderate Buy
Incyte
$97.82
$19.39B
15.46
48.67%
8 Buy
9 Hold
1 Sell
Moderate Buy
Ascendis Pharma
$244.48
$15.05B
4.77
49.37%
12 Buy
0 Hold
0 Sell
Strong Buy
BioNTech SE
$102.92
$22.85B
-8.99
-11.17%
14 Buy
2 Hold
0 Sell
Strong Buy
Royalty Pharma
$50.00
$30.56B
17.56
60.35%
7 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GMAB
Genmab
27.21
6.69
32.60%
BMRN
BioMarin Pharmaceutical
50.20
-8.28
-14.16%
INCY
Incyte
97.08
32.30
49.86%
ASND
Ascendis Pharma
241.34
83.24
52.65%
BNTX
BioNTech SE
90.36
-8.73
-8.81%
RPRX
Royalty Pharma
53.06
20.92
65.09%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts